Tropical Weather Alert: For the latest updates on closures or modified hours for our UF Health clinical facilities, click here
Rhabdomyosarcoma
Related specialties
Our locations
Clinical Trials: Rhabdomyosarcoma
UF Health research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:
The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docetaxel) can improve outcomes in people with…
- Investigator
- John A Ligon
- Status
- Accepting Candidates
- Ages
- 12 Years - 40 Years
- Sexes
- All
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using…
- Investigator
- William Slayton
- Status
- Accepting Candidates
- Ages
- N/A - 21 Years
- Sexes
- All
News and Patient Stories: Rhabdomyosarcoma
UF Health adolescent and young adult cancer program expands
September 12, 2024
GAINESVILLE, Fla. — Eight years ago, Jennifer Arrington was simultaneously planning her unborn son’s funeral and her own. Diagnosed with a rare pediatric…
College of Medicine, UF Health Cancer Center, +2 more
Get the Facts on Childhood Rhabdomyosarcoma
July brings awareness to the cancer that is responsible for 10 percent of all childhood cancer-related deaths: sarcoma. In recognition of Sarcoma Awareness…